Specializing in immunology and the immunogenicity of therapeutic proteins, Dr. Bernard Maillère is a recognized expert in T epitope analysis, biotherapy development, and the immunological risk assessment of therapeutic proteins. He has led international research projects, supervised PhD students, and collaborated with industry on the design of experimental models and advanced immunological analysis tools.

• Immunology
• Immunogenicity
• T Epitopes
• Biotherapies
• Experimental Models